Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid

Siew-Na Lim, Wenlong Huang, Jodie C E Hall, Adina T Michael-Titus, John V Priestley

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

In this study we have characterised the locomotor recovery, and temporal profile of cell loss, in a novel thoracic compression spinal cord injury (SCI) in the mouse. We have also shown that treatment with docosahexaenoic acid (DHA) is neuroprotective in this model of SCI, strengthening the growing literature demonstrating that omega-3 polyunsaturated fatty acids are neuroprotective after SCI. Compression SCI in C57BL/6 mice was produced by placing a 10 g weight for 5 min onto a 2 mm × 1.5 mm platform applied to the dura at vertebral level T12. Mice partly recovered from complete hindlimb paralysis and by 28 days post-surgery had plateaued at an average BMS locomotor score of 4.2, equivalent to weight support with plantar stepping. During the same period, neuronal loss at the epicentre increased from 26% of ventral horn neurons by day 1, to 68% by day 28. Delayed loss of oligodendrocytes was also seen (e.g. 84% by day 28 in the dorsal columns) and microglia/macrophage activation was maximal at 7 days. In contrast, axonal damage, judged by a decrease in the non-phosphorylated form of 200 kD neurofilament, was an early event, as the loss was seen by day 1 and did not change markedly over time. Mice that received an intravenous (i.v.) injection of 500 nmol/kg DHA 30 min after SCI, showed improved locomotor recovery and, at 28 day survival, reduced neuronal, oligodendrocyte and neurofilament loss, and reduced microglia/macrophage activation. For some of these indices of SCI, enrichment of the diet with 400 mg/kg/day DHA led to further improvement. However, dietary DHA supplementation, without the initial i.v. injection, was ineffective.

Original languageEnglish
Pages (from-to)13-27
Number of pages15
JournalExperimental Neurology
Volume239
Early online date28 Sep 2012
DOIs
Publication statusPublished - Jan 2013

Fingerprint

Spinal Cord Compression
Docosahexaenoic Acids
Spinal Cord Injuries
Macrophage Activation
Oligodendroglia
Microglia
Intravenous Injections
Anterior Horn Cells
Weights and Measures
Intermediate Filaments
Omega-3 Fatty Acids
Hindlimb
Ambulatory Surgical Procedures
Unsaturated Fatty Acids
Inbred C57BL Mouse
Paralysis
Thorax
Diet

Keywords

  • Animals
  • Cell Survival
  • Diet
  • Docosahexaenoic Acids
  • Female
  • Image Processing, Computer-Assisted
  • Immunohistochemistry
  • Injections, Intravenous
  • Locomotion
  • Macrophage Activation
  • Mice
  • Mice, Inbred C57BL
  • Microglia
  • Neurofilament Proteins
  • Neurons
  • Oligodendroglia
  • Paralysis
  • Recovery of Function
  • Spinal Cord Compression
  • Survival Analysis
  • Treatment Outcome
  • Trauma
  • Spinal Cord Injury
  • Polyunsaturated Fatty Acid
  • Docosahexaenoic Acid
  • Neuroprotection

Cite this

Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. / Lim, Siew-Na; Huang, Wenlong; Hall, Jodie C E; Michael-Titus, Adina T; Priestley, John V.

In: Experimental Neurology, Vol. 239, 01.2013, p. 13-27.

Research output: Contribution to journalArticle

Lim, Siew-Na ; Huang, Wenlong ; Hall, Jodie C E ; Michael-Titus, Adina T ; Priestley, John V. / Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid. In: Experimental Neurology. 2013 ; Vol. 239. pp. 13-27.
@article{3022e70a29b04fd8ac292ca736b81a88,
title = "Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid",
abstract = "In this study we have characterised the locomotor recovery, and temporal profile of cell loss, in a novel thoracic compression spinal cord injury (SCI) in the mouse. We have also shown that treatment with docosahexaenoic acid (DHA) is neuroprotective in this model of SCI, strengthening the growing literature demonstrating that omega-3 polyunsaturated fatty acids are neuroprotective after SCI. Compression SCI in C57BL/6 mice was produced by placing a 10 g weight for 5 min onto a 2 mm × 1.5 mm platform applied to the dura at vertebral level T12. Mice partly recovered from complete hindlimb paralysis and by 28 days post-surgery had plateaued at an average BMS locomotor score of 4.2, equivalent to weight support with plantar stepping. During the same period, neuronal loss at the epicentre increased from 26{\%} of ventral horn neurons by day 1, to 68{\%} by day 28. Delayed loss of oligodendrocytes was also seen (e.g. 84{\%} by day 28 in the dorsal columns) and microglia/macrophage activation was maximal at 7 days. In contrast, axonal damage, judged by a decrease in the non-phosphorylated form of 200 kD neurofilament, was an early event, as the loss was seen by day 1 and did not change markedly over time. Mice that received an intravenous (i.v.) injection of 500 nmol/kg DHA 30 min after SCI, showed improved locomotor recovery and, at 28 day survival, reduced neuronal, oligodendrocyte and neurofilament loss, and reduced microglia/macrophage activation. For some of these indices of SCI, enrichment of the diet with 400 mg/kg/day DHA led to further improvement. However, dietary DHA supplementation, without the initial i.v. injection, was ineffective.",
keywords = "Animals, Cell Survival, Diet, Docosahexaenoic Acids, Female, Image Processing, Computer-Assisted, Immunohistochemistry, Injections, Intravenous, Locomotion, Macrophage Activation, Mice, Mice, Inbred C57BL, Microglia, Neurofilament Proteins, Neurons, Oligodendroglia, Paralysis, Recovery of Function, Spinal Cord Compression, Survival Analysis, Treatment Outcome, Trauma, Spinal Cord Injury, Polyunsaturated Fatty Acid, Docosahexaenoic Acid, Neuroprotection",
author = "Siew-Na Lim and Wenlong Huang and Hall, {Jodie C E} and Michael-Titus, {Adina T} and Priestley, {John V}",
note = "Copyright {\circledC} 2012 Elsevier Inc. All rights reserved.",
year = "2013",
month = "1",
doi = "10.1016/j.expneurol.2012.09.015",
language = "English",
volume = "239",
pages = "13--27",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",

}

TY - JOUR

T1 - Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid

AU - Lim, Siew-Na

AU - Huang, Wenlong

AU - Hall, Jodie C E

AU - Michael-Titus, Adina T

AU - Priestley, John V

N1 - Copyright © 2012 Elsevier Inc. All rights reserved.

PY - 2013/1

Y1 - 2013/1

N2 - In this study we have characterised the locomotor recovery, and temporal profile of cell loss, in a novel thoracic compression spinal cord injury (SCI) in the mouse. We have also shown that treatment with docosahexaenoic acid (DHA) is neuroprotective in this model of SCI, strengthening the growing literature demonstrating that omega-3 polyunsaturated fatty acids are neuroprotective after SCI. Compression SCI in C57BL/6 mice was produced by placing a 10 g weight for 5 min onto a 2 mm × 1.5 mm platform applied to the dura at vertebral level T12. Mice partly recovered from complete hindlimb paralysis and by 28 days post-surgery had plateaued at an average BMS locomotor score of 4.2, equivalent to weight support with plantar stepping. During the same period, neuronal loss at the epicentre increased from 26% of ventral horn neurons by day 1, to 68% by day 28. Delayed loss of oligodendrocytes was also seen (e.g. 84% by day 28 in the dorsal columns) and microglia/macrophage activation was maximal at 7 days. In contrast, axonal damage, judged by a decrease in the non-phosphorylated form of 200 kD neurofilament, was an early event, as the loss was seen by day 1 and did not change markedly over time. Mice that received an intravenous (i.v.) injection of 500 nmol/kg DHA 30 min after SCI, showed improved locomotor recovery and, at 28 day survival, reduced neuronal, oligodendrocyte and neurofilament loss, and reduced microglia/macrophage activation. For some of these indices of SCI, enrichment of the diet with 400 mg/kg/day DHA led to further improvement. However, dietary DHA supplementation, without the initial i.v. injection, was ineffective.

AB - In this study we have characterised the locomotor recovery, and temporal profile of cell loss, in a novel thoracic compression spinal cord injury (SCI) in the mouse. We have also shown that treatment with docosahexaenoic acid (DHA) is neuroprotective in this model of SCI, strengthening the growing literature demonstrating that omega-3 polyunsaturated fatty acids are neuroprotective after SCI. Compression SCI in C57BL/6 mice was produced by placing a 10 g weight for 5 min onto a 2 mm × 1.5 mm platform applied to the dura at vertebral level T12. Mice partly recovered from complete hindlimb paralysis and by 28 days post-surgery had plateaued at an average BMS locomotor score of 4.2, equivalent to weight support with plantar stepping. During the same period, neuronal loss at the epicentre increased from 26% of ventral horn neurons by day 1, to 68% by day 28. Delayed loss of oligodendrocytes was also seen (e.g. 84% by day 28 in the dorsal columns) and microglia/macrophage activation was maximal at 7 days. In contrast, axonal damage, judged by a decrease in the non-phosphorylated form of 200 kD neurofilament, was an early event, as the loss was seen by day 1 and did not change markedly over time. Mice that received an intravenous (i.v.) injection of 500 nmol/kg DHA 30 min after SCI, showed improved locomotor recovery and, at 28 day survival, reduced neuronal, oligodendrocyte and neurofilament loss, and reduced microglia/macrophage activation. For some of these indices of SCI, enrichment of the diet with 400 mg/kg/day DHA led to further improvement. However, dietary DHA supplementation, without the initial i.v. injection, was ineffective.

KW - Animals

KW - Cell Survival

KW - Diet

KW - Docosahexaenoic Acids

KW - Female

KW - Image Processing, Computer-Assisted

KW - Immunohistochemistry

KW - Injections, Intravenous

KW - Locomotion

KW - Macrophage Activation

KW - Mice

KW - Mice, Inbred C57BL

KW - Microglia

KW - Neurofilament Proteins

KW - Neurons

KW - Oligodendroglia

KW - Paralysis

KW - Recovery of Function

KW - Spinal Cord Compression

KW - Survival Analysis

KW - Treatment Outcome

KW - Trauma

KW - Spinal Cord Injury

KW - Polyunsaturated Fatty Acid

KW - Docosahexaenoic Acid

KW - Neuroprotection

U2 - 10.1016/j.expneurol.2012.09.015

DO - 10.1016/j.expneurol.2012.09.015

M3 - Article

VL - 239

SP - 13

EP - 27

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -